National Community Pharmacists Association
FDANonrulemakingFDA-2023-D-0939

Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability

RIN
Last modified
Feb 4, 2025
Comment window
closed 1065d ago
National Community Pharmacists Association filings
1

Activity

National Community Pharmacists Association filed 1 comment on this docket between Aug 28, 2023 and Aug 28, 2023. 0 other organizations filed here. The comment window closed 1065d ago.

What National Community Pharmacists Association filed (1)

Aug 28, 2023· Comment from National Community Pharmacists Association· FDA-2023-D-0939-0094

The National Community Pharmacists Association (NCPA) writes today to provide feedback on FDA's draft guidance: Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act. Attached are our full comments.

Abstract

No abstract recorded.

View on regulations.gov →
Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability (FDA) — National Community Pharmacists Association | OpenPolis